These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3448056)

  • 1. Renal involvement in type 2 diabetes mellitus: a clinicopathologic study of the Henry Ford Hospital experience.
    Dumler F; Kumar V; Romanski RN; Cortes P; Levin NW
    Henry Ford Hosp Med J; 1987; 35(4):221-5. PubMed ID: 3448056
    [No Abstract]   [Full Text] [Related]  

  • 2. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes.
    Cowie CC; Port FK; Wolfe RA; Savage PJ; Moll PP; Hawthorne VM
    N Engl J Med; 1989 Oct; 321(16):1074-9. PubMed ID: 2797067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in survival between black and white patients with diabetic end-stage renal disease.
    Cowie CC; Port FK; Rust KF; Harris MI
    Diabetes Care; 1994 Jul; 17(7):681-7. PubMed ID: 7924777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic renal disease in blacks--inevitable or preventable?
    Rostand SG
    N Engl J Med; 1989 Oct; 321(16):1121-2. PubMed ID: 2797070
    [No Abstract]   [Full Text] [Related]  

  • 5. Incidence of treatment for end-stage renal disease attributed to diabetes mellitus--United States, 1980-1989.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1992 Nov; 41(44):834-7. PubMed ID: 1435669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the distal region of the ectonucleotide pyrophosphatase/phosphodiesterase 1 gene with type 2 diabetes in an African-American population enriched for nephropathy.
    Keene KL; Mychaleckyj JC; Smith SG; Leak TS; Perlegas PS; Langefeld CD; Freedman BI; Rich SS; Bowden DW; Sale MM
    Diabetes; 2008 Apr; 57(4):1057-62. PubMed ID: 18184924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NIDDM is the major cause of diabetic end-stage renal disease. More evidence from a tri-ethnic community.
    Pugh JA; Medina RA; Cornell JC; Basu S
    Diabetes; 1995 Dec; 44(12):1375-80. PubMed ID: 7589841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapidly progressive renal failure with nephrotic syndrome in a patient with type 2 diabetes mellitus: the differential of fibrillary deposits.
    Ovuworie C; Volmar K; Charney D; Kravet S; Racusen L
    Am J Kidney Dis; 2000 Jan; 35(1):173-7. PubMed ID: 10620562
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetes-related end-stage renal disease in Missouri: trends and variations by age and race.
    Urriola-Acheson A; Sharp DJ; Kruse KH; Austin DE; Weaver A; Brownson RC
    Mo Med; 1994 Jun; 91(6):287-90. PubMed ID: 8052218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the patterns of age-specific black/white comparisons between end-stage renal disease attributed and not attributed to diabetes.
    Lopes AA; Port FK
    Am J Kidney Dis; 1995 May; 25(5):714-21. PubMed ID: 7747725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial differences in the incidence of end-stage renal disease in types I and II diabetes mellitus.
    Stephens GW; Gillaspy JA; Clyne D; Mejia A; Pollak VE
    Am J Kidney Dis; 1990 Jun; 15(6):562-7. PubMed ID: 2368696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of diabetic nephropathy in non-insulin-dependent diabetes mellitus.
    Nelson RG; Knowler WC; Bennett PH
    J Diabet Complications; 1991; 5(2-3):76-8. PubMed ID: 1770058
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of coding variants identified from exome sequencing resources for association with diabetic and non-diabetic nephropathy in African Americans.
    Bailey JNC; Palmer ND; Ng MCY; Bonomo JA; Hicks PJ; Hester JM; Langefeld CD; Freedman BI; Bowden DW
    Hum Genet; 2014 Jun; 133(6):769-779. PubMed ID: 24385048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal pathological implications in type 2 diabetes mellitus patients with renal involvement.
    Li L; Zhang X; Li Z; Zhang R; Guo R; Yin Q; Yang L; Yue R; Su B; Huang S; Xu H; He C; Liu F
    J Diabetes Complications; 2017 Jan; 31(1):114-121. PubMed ID: 27838100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension does not contribute to end-stage renal disease in black recipients of kidney/pancreas transplants.
    Froelich J; Posner M; Beck R; Tesi RJ
    Transplant Proc; 1997 Dec; 29(8):3718. PubMed ID: 9414899
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetes and end-stage renal failure.
    Catalano C; Cuzzola F; Enia G; Maggiore Q
    Lancet; 1987 May; 1(8543):1201. PubMed ID: 2883509
    [No Abstract]   [Full Text] [Related]  

  • 17. Racial factors in the incidence and causation of end-stage renal disease (ESRD).
    Easterling RE
    Trans Am Soc Artif Intern Organs; 1977; 23():28-33. PubMed ID: 910346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic nephropathy in blacks.
    Friedman EA
    Transplant Proc; 1993 Aug; 25(4):2431-2. PubMed ID: 8356622
    [No Abstract]   [Full Text] [Related]  

  • 19. Progression of diabetic kidney disease and trajectory of kidney function decline in Chinese patients with Type 2 diabetes.
    Jiang G; Luk AOY; Tam CHT; Xie F; Carstensen B; Lau ESH; Lim CKP; Lee HM; Ng ACW; Ng MCY; Ozaki R; Kong APS; Chow CC; Yang X; Lan HY; Tsui SKW; Fan X; Szeto CC; So WY; Chan JCN; Ma RCW;
    Kidney Int; 2019 Jan; 95(1):178-187. PubMed ID: 30415941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of end-stage renal failure and severe retinopathy in type 2 diabetes.
    Slama G; Penfornis A; Haardt MJ; Altman JJ; Besse A
    Lancet; 1992 Jan; 339(8787):244-5. PubMed ID: 1346197
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.